IGEA PHARMA
IGEA Pharma N.V. focuses on health-tech and med-tech products and devices. IGEA commercializes an Alzheimer's prevention set (which includes 'Alz1', an at-home lab test kit to measure non-bound copper in the blood and a natural dietary supplement branded 'Alz1 Tab' designed to reduce blood heavy metals content) and expects to integrate the non-bound copper detection-based pipeline with a diabetes type II prevention set in 2021.
IGEA PHARMA
Industry:
Biotechnology Health Care
Founded:
2018-01-01
Address:
Hoofddorp, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.igeapharma.nl
Status:
Active
Contact:
+31 23 568 94 94
Email Addresses:
[email protected]
Total Funding:
2 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag Google Maps
Similar Organizations
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Stock Details
Investors List
Negma Group
Negma Group investment in Post-IPO Debt - Igea Pharma
Official Site Inspections
http://www.igeapharma.nl
- Host name: 114.162.214.35.bc.googleusercontent.com
- IP address: 35.214.162.114
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Igea Pharma"
IGEA Pharma N.V. Annual report 2019
IGEA Pharma N.V. www.igeapharma.nl Section II - Corporate Governance This Corporate Governance Report follows the SIX Swiss Exchange Directive on Information relating to …See details»
Igea Pharma - Crunchbase Company Profile & Funding
Aug 4, 2019 IGEA Pharma N.V. focuses on health-tech and med-tech products and devices. IGEA commercializes an Alzheimer's prevention set (which includes 'Alz1', an at-home lab test …See details»
IGEA Pharma N.V. Annual report 2022
IGEA Pharma N.V. www.igeapharma.nl Section I - Management review 2022 1 Company profile IGEA Pharma N.V. focuses on highly controlled vegetable matrices and their industrial …See details»
IGEA Pharma N.V. Annual report 2020
IGEA Pharma N.V. www.igeapharma.nl Section I - Management review 2020 1 Company profile IGEA Pharma N.V. focuses on health-tech and med-tech products and devices. Health-tech …See details»
IGEA Pharma N.V., Financial Info, Board and Management, …
Changes In Board and Management in last 6 months: Men: 0 Women: 0 GENDER BALANCESee details»
IGEA Pharma: Annual report - MarketScreener
May 31, 2021 www.igeapharma.nl Key elements of the Combination strategy include establish market acceptance and position for the offered solutions, leverage commercial capabilities and …See details»
Company IGEA Pharma N.V. - MarketScreener.com
Dec 13, 2018 IGEA Pharma N.V.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Swiss Exchange: IGPH | …See details»
IGEA Pharma - Overview, News & Similar companies - ZoomInfo
Dec 9, 2022 View IGEA Pharma (www.igeapharma.nl) location in North Holland, Netherlands , revenue, industry and description. Find related and similar companies as well as employees …See details»
IGEA Pharma - Products, Competitors, Financials, Employees ...
IGEA Pharma is a holding company involved in the healthcare and pharmaceutical sectors, focusing on natural resources for functional foods, food supplements, and products for the …See details»
IGEA Pharma NV: Drug pipelines, Patents, Clinical trials - Synapse
Jun 29, 2023 Explore IGEA Pharma NV with its drug pipeline, therapeutic area, technology platform, .See details»
Delisting of IGEA Pharma N.V., Hoofddorp NL – Formal delisting
Dec 19, 2023 By decision of 31 October 2023, the Appeals Board of SIX Group AG dismissed the appeal of IGEA Pharma N.V. against the decision of the Regulatory Board of SIX Group …See details»
IGEA Pharma N.V. - Laboratorium.nl
IGEA Pharma N.V. richt zich op health-tech en med-tech producten en apparaten. Health-tech producten zijn uitsluitend preventief. IGEA brengt een Alzheimer-preventieset op de markt …See details»
IGEA Pharma N.V.: IGEA and RBCARE2023 signed to combine their ...
Oct 3, 2023 Pierpaolo Cerani, CEO, [email protected] . Disclaimer. This document does neither constitute an offer to buy or to subscribe for securities of IGEA nor a prospectus within …See details»
IGEA Pharma N.V. Annual report 2018
IGEA Pharma N.V. www.igeapharma.nl Section I - Management review 2018 1 Company profile 1.1 Business IGEA Pharma N.V. is a health-tech company focused on measure and control of …See details»
IGEA Pharma N.V.: IGEA to get SIX further approval to the 2021 …
Jul 15, 2022 I. The exemption application of IGEA (Issuer) dated 15 July 2022 requesting a third extension of the deadline to publish its 2021 annual report and to file such report withSee details»
IGEA Pharma N.V. Interim financial reporting June 2020
IGEA Pharma N.V. www.igeapharma.nl Interim condensed consolidated financial statements Condensed consolidated balance sheet, unaudited (in thousand USD, unless otherwise …See details»
Working at IGEA PHARMA - Glassdoor
Glassdoor gives you an inside look at what it's like to work at IGEA PHARMA, including salaries, reviews, office photos, and more. This is the IGEA PHARMA company profile.See details»
IGEA Pharma N.V. Interim financial reporting June 2021
IGEA Pharma N.V. www.igeapharma.nl Condensed consolidated statement of changes in equity, unaudited (in thousand USD, unless otherwise stated) The accompanying notes are an …See details»
About BC Care N.V. – BC Care
About BC Care N.V. BC Care focuses on health-tech and med-tech products and devices. Health-tech products are exclusively preventative. BC Care commercializes an Alzheimer’s …See details»
Press releases/News – BC Care - igeapharma.nl
Oct 4, 2023 Hoofddorp, the Netherlands, 6 March 2024. ForHealthy NV (formerly IGEA Pharma NV) today announced that its extraordinary general meeting held on 27 February 2024 has …See details»